Abstract
Tricuspid annuloplasty for moderate to severe TR (Class I, IIb)
is the current standard of practice to restore the normal tricuspid
annular dimension and function (1,2). The current controversy in
atrioventricular surgery concerns the indication for concomitant TA in
patients with moderate TR and significant annular dilatation of at
least > 40 mm or at least 21
mm/m2 indexed for body surface area (Class IIb) during
mitral valve surgery proposed by the American Heart Association/American
College of Cardiology and European Society of Cardiology (1,2,3)
